Periodicidad semestral: flujo continuo.
ISSN - Electrónico: 2661-6947 / DOI: 10.36015 • LILACS BIREME (19784); LATINDEX (20666)
Introduction: infections due to community-acquired Staphylococcus aureus (MRSA -AC) are increasing signifcantly worldwide. Its virulence is mainly characterized by the presence of Panton- Valentine Leukocidin. This study pretends to analyze the importance of studying antibiotic sensitivity of community- acquired S. aureus, which determines appropriate management and early treatment of these infections. Case study: we present two cases in Ecuadorian children who had the characteristics of MRSA-AC.
REFERENCIAS BIBLIOGRÁFICAS
Udo EE, Pearman a JW, Grubb WB. Genetic análisis of community isolates of methicillin resistan Staphilococcus aureus in Western Australia. J Hosp Infect 1993;25:97-108
Hiramatsu K, Okuma K, Ma XX, Yamamoto M, Hori S, Kapi M. New trends inStaphilococcus aureus infections: glycopeptide resistance in hospital and methicillin resistance in the community. Current Opinion in Infectious Diseases 2000; 15: 407-413
Medscape: MRSA Strains Spreading Outside US Hospitals. Reuters Health Information 2004. © 2004 Reuters Ltd.
Bertaux O, Constenla I, Pedreira W, Galiana A, Bagnulo H. Staph. Aureus resistente a meticilina de la comunidad: causante de sepsis y neumonia necrotizante. Congreso Argentina SADI. Mar el Plata, mayo 2004
Galiana A, Pedreira W, Hiramatsu K, Bertaux O, Constenla I, Bagnulo H, Christophersen Praga 2004
Ewing S, Torres A. Severe community acquired pneumona. Chest 1999; 20:575-587
Correa H, Morelli R. Infecciones graves de partes blandas. En: Sepsis. Tratamiento intensivo de las infecciones graves. Humberto Correa. Oficina del Libro FEFMUR. Montevideo 2008
Capnick, EK, Abter IA. Necrotizing soft tissue infection. Infect Dis North Am 1996;10:835-856
Lundstrom TS, Sobel JD. Vancomicyn, trmethoprim sulfamethoxazole, and rifampin. Infect Dis Clin North Am 1995;9:747-781
Gilbert DV; Moellering RC, Sande MA. Guide to antimicrobial therapy. Sandoford guide 2009
Wunderink RG, Rello J, y cols. Linezolid vs vancomycin: analysis of two double blind studies of patients with methicillin resistant staphylococcus aureus nosocomial pneumonia. Chest 2009; 124:1789-1797
Fekety R. Vancomicina, teicoplanina yas estreptograminas: quinupristina y dalfopristina. En: Mandell, Douglas, Bennett. Principles and practice of infectious diseases, 5th ed. 2000 Churchill Livingstone. A harcourt Health Sciences Company, Philadelphia
Skov R, Smyth R, Clausen M et al. Evaluation of a cefoxitindisc on Iso Sensitest agar for detection of methicillin resistant Staphylococcus aureus. J Antimicrob Chemother. 2003; 52(2):204-7
Huang MB, Gay TE, Baker CN et al. Two percent sodium chloride is required for susceptibility testing of staphylococci with oxacillin when using agar based dilution methods. J Clin Microbiol. 1993; 31(10):2683-8
Novak SM, Hindler J, Bruckner DA. Reliability of two novelmethods, Alamar and E test, for detection of methicillin resistant Staphylococcus aureus. J Clin Microbiol. 2010 31(11):3056-7
Petersson AC, Miorner H, Kamme C. Identification of mec Arelated oxacillin resistance in staphylococci by the E test and the broth microdilution method. J Antimicrob Chemother. 1996;37(3):445-56
Weller TM, Crook DW, Crow MR et al. Methicillin susceptibility testing of staphylococci by Etest and comparison with agar dilution and mec A detection. J Antimicrob Chemother. 1997; 39(2):251-3
Perry JD, Rennison C, Butterworth LA et al. Evaluation of S. aureus ID, a new chromogenic agar medium for detection of phenotype. 2010
The authors who publish in this journal accept the following conditions:
1. The authors retain the copyright and grant to the CAMbios MEDICAL-SCIENTIFIC JOURNAL HECAM the right of the first publication, with the work registered with the Creative Commons attribution license, which allows third parties to use the published material provided that they mention the authorship of the work and the first publication in this journal.
2. Authors can make other independent and additional contractual agreements for the non-exclusive distribution of the version of the article published in this journal (for example, include it in an institutional repository or publish it in a book) as long as it clearly indicates that the work was published. for the first time in the CAMbios MEDICAL-SCIENTIFIC JOURNAL HECAM.